Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
DarioHealth Corp. has added six new employer clients across sectors such as manufacturing and education, representing tens of thousands of employees, and introduced a new value-based pricing model linking payments to engagement and clinical outcomes.
The Novo Nordisk Foundation has committed up to DKK 200 million to establish the Global Pathogen Analysis Platform, an AI-powered infrastructure aimed at strengthening global pandemic preparedness through open genomic data analysis tools.
EY has acquired Greece-based Veeva services partner Aqurance to strengthen its Veeva Centers of Excellence and expand clinical, regulatory, and commercial capabilities for global life sciences clients.
Cumulus Neuroscience presented new data at the ISCTM Autumn Conference and ECNP Congress, highlighting the use of its NeuLogiq Platform for digital biomarkers in CNS clinical trials. The company showcased studies on major depressive disorder and dementia, showing improved sensitivity and efficiency in trial design.
AcuityMD has announced an expansion of its AI platform, introducing new tools to improve sales performance and strategic decision-making for medical device companies.
Notable has introduced Flow AI, a conversational assistant designed to streamline workflow automation in healthcare, as announced in a press release.
Hahn Labs has launched a new AI-powered solution to streamline healthcare call handling during open enrollment, significantly reducing wait times and costs.
Hoth Therapeutics has expanded its AI initiative by adopting the NVIDIA AI Enterprise platform to enhance drug development and predictive analytics.
Nucs AI has announced the expansion of its leadership team with new appointments to advance AI-driven prostate cancer diagnostics and treatment planning.
DPR Construction's latest report reveals how AI is transforming healthcare construction by improving project delivery and efficiency.
BD and Opentrons have announced a multi-year collaboration to integrate robotic automation into BD's single-cell multiomics instruments, enhancing disease research and drug development.
POMDOCTOR Limited, a leading online medical services platform in China, has announced the pricing of its initial public offering on Nasdaq, aiming to raise approximately $20 million.
TransCelerate BioPharma is pushing forward with its Digital Data Flow initiative to modernize clinical trials through digital protocols, as announced in a recent press release.
InsightRX, a leader in precision dosing AI solutions, has been recognized in the 2025 KLAS Emerging Company Spotlight report with a performance score of 96.1, highlighting its impact on clinical decision support.
Qualtrics has announced a $6.75 billion acquisition of Press Ganey Forsta, aiming to enhance AI-powered experience management in healthcare.
AstraZeneca has entered a $555 million partnership with Algen Biotechnologies to develop gene-editing therapies using AI and CRISPR technology.
Made Scientific and Streamline Bio have successfully validated Streamline Bio's AI-driven robotics platform in a live cell therapy production environment, as announced in a press release. The collaboration aims to integrate the platform into GMP cleanrooms for commercial-scale implementations.
Halia Therapeutics has appointed Paul Jones as Chief Strategy Officer & GM, International Markets to accelerate its GENMOR-AI platform, according to a press release.
Heidi, a Melbourne-based AI startup, has raised $65 million in a Series B funding round led by Point72 Private Investments, boosting its valuation to $465 million.
A Microsoft-led team discovered that AI-generated toxins can bypass DNA security measures, prompting a call for improved biosecurity protocols.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
